Watch the ERP systems compliance and validation webinar!

Go to Webinar
(312) 207-5800

Quality Management System Validation Best Practices for Life Sciences Companies

In today’s digitized life sciences landscape, spanning pharmaceuticals, biotechnology, medical devices, diagnostics, and contract manufacturing organizations, quality is no longer simply the function of documentation or process discipline. It’s a strategic differentiator. Cloud-based Quality Management System (QMS) FDA expectations and QMS validation demands have converged to create a pivotal moment for organizations seeking faster time-to-market, reduced compliance risk, and scalable operational excellence. 

Why Cloud QMS  and Why Validate? 

A cloud-based QMS offers clear advantages over traditional on-premises deployments: lower total cost of ownership, faster implementation, continuous innovation, and elastic scalability. However, in regulated industries, quality is bound to the rigor of compliance. That’s where QMS GxP validation comes in. Validation demonstrates, through documented evidence, that the software consistently performs according to its intended use and regulatory requirements across its lifecycle. 

Cloud platforms can be stood up in weeks, but without validation, teams cannot leverage the system for production GxP records. Validation accelerates safe adoption and reduces the likelihood of quality events, inspection findings, and data integrity issues by ensuring the system is controlled, traceable, and built with compliance in mind.

For organizations engaging with the US Food and Drug Administration (FDA), European Medicines Agency (EMA), the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), and Japan’s Pharmaceuticals and Medical Devices Agency (PMDA), a validated quality management software signals that the organization treats data, workflows, and records with the rigor expected in a regulated environment. 

Cloud-Specific GxP Considerations 

Validating a cloud-based QMS introduces nuances beyond traditional on-premise systems. Consider the following: 

  • Shared Responsibility Model: In a cloud QMS environment, responsibilities are divided between the vendor and the customer. Vendors manage infrastructure, security baselines, and platform operations, while customers are accountable for system configuration, intended use, and procedural controls. Clearly defining and documenting these responsibilities is essential for maintaining GxP compliance and ensuring the validated state throughout the system lifecycle. 
  • Controlled Change Cadence: Cloud QMS updates occur frequently in a software-as-a-service (SaaS) environment, introducing potential risks to validated systems and GxP compliance. To preserve the validated state, organizations must implement a robust change control process that includes pre-release impact assessments, risk evaluations, regression testing, and documented approvals. This structured approach ensures that all changes are properly assessed for their impact on regulatory requirements and that validation integrity is maintained throughout the system lifecycle.  

  • Multi-Tenant Architecture: Validation should assess how multi-tenant controls ensure segregation of tenant data, role segmentation, and privacy protections without compromising performance or security. This assessment is critical for demonstrating compliance with data integrity requirements and regulatory expectations in a shared cloud environment. 
  • Qualification of Vendors (Supplier Qualification): Treat your cloud QMS provider as a critical GxP supplier. Audit their QMS, review SOC/ISO certifications, service level agreements (SLAs), disaster recovery posture, and evidence of software development lifecycle (SDLC) controls. 
  • Data Integrity by Design: Ensure that the platform enforces audit trails, version control, electronic signatures, time-stamping, and immutable record retention. Verify that these features are properly implemented and configured to align with the Company’s processes and compliance requirements. 
  • Business Continuity & Disaster Recovery: Validate Recovery Point Objective (RPO) / Recovery Time Objective (RTO) targets, failover procedures, and periodic testing of restore processes. In a regulated environment, data restoration isn’t just an IT task, but rather it’s a quality requirement. 

Arbour Group’s Approach to QMS GxP Validation

With over 30 years of dedicated expertise in life sciences and a proven track record of supporting more than 300 clients globally, Arbour Group understands the unique challenges of achieving GxP compliance in cloud environments.

Our comprehensive cloud QMS validation package enables life sciences organizations to maintain a validated state throughout the system lifecycle. By applying a risk-based validation approach aligned with FDA, EMA, and global regulatory expectations, we ensure continuous compliance and audit readiness - empowering innovation without compromising patient safety or data integrity.

Arbour Group’s QMS validation methodology consistently aligns with GxP principles, including ALCOA+, and encompasses the following key elements:

  1. Validation Planning: The Validation Plan defines the scope of activities, roles and responsibilities, deliverables, and the overall strategy for validating the system. This plan incorporates a comprehensive risk assessment to identify potential vulnerabilities and prioritize critical areas, ensuring that validation efforts are both efficient and effective.

    Arbour Group ensures the alignment between business objectives and regulatory requirements, offering transparency and traceability throughout the lifecycle of the system. It outlines the approach for qualification protocols – such as Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) – and specifies acceptance criteria for defined test objectives.

    Additionally, the validation Plan addresses documentation standards, change control procedures, and contingency measures to maintain compliance in dynamic environments. By establishing clear expectations and governance, the Validation Plan not only mitigates compliance risks but also promotes consistency, audit readiness, and confidence in system reliability. Ultimately, it sets the foundation for a validation process that is robust, repeatable, and aligned with industry best practices.

  2. Evaluation of Cloud Infrastructure’s Complementary User Entity Controls (CUECs): SOC reports (e.g., for AWS, Azure, or any cloud infrastructure hosting the QMS) include CUECs – controls customers must implement to achieve overall security and compliance objectives. Arbour Group ensures these are evaluated and documented, as they are critical for maintaining a validated state and meeting regulatory expectations for data integrity and business continuity.

  3. Requirements and Intended use: The User Requirements and Functional Specifications (URFS) define clear, testable statements of both functional and regulatory requirements, such as, electronic signatures, audit trails, data integrity, role-based access, backup/restore capabilities, and system availability – aligned with the system’s intended use. These specifications form the foundation for risk-based validation and ensure compliance with GxP principles and applicable regulations (e.g., FDA 21 CFR Part 11, EU Annex 11).

  4. Risk-Based Approach: In GxP validation, not all system features carry the same level of risk. A risk-based strategy prioritizes testing depth and documentation effort on functions that directly impact product quality, patient safety, or data integrity. This approach aligns with regulatory expectations (e.g., FDA, EMA, MHRA) and ensures resources are focused where compliance risk is greatest, while maintaining efficiency and validation integrity.

  5. Testing and Qualification (IQ/OQ/PQ): Leveraging the results of the risk assessment, Arbour Group, working closely with Quality Assurance (QA) – determines the appropriate level of testing rigor for each identified functional and system requirement. This ensures that validation activities are proportionate to the potential impact on product quality, patient safety, and data integrity, fully aligning with regulatory expectations and supporting a robust risk-based validation strategy. Testing is executed using the following qualification protocols:
    • Installation Qualification (IQ): Verifies that the system environment, including all components and its versions, is correctly installed and configured according to specifications.
    • Operational Qualification (OQ): Validates core system operations and functionalities to ensure they function as intended. OQ testing confirms that workflows, configurations, and compliance-critical features – such as audit trails, electronic signatures, and security controls, function correctly. This process ensures the system meets defined functional specifications and adheres to applicable regulatory requirements.
    • Performance Qualification (PQ): Performs validation of end-to-end business processes using representative users with appropriate roles and access rights, and approved system configuration. This activity verifies that the system consistently supports the Quality Management System (QMS) in routine operations and produces documented evidence demonstrating that the system is suitable for its intended use.

  6. Traceability: The Validation Traceability Matrix ensures that each User Requirement (UR) is linked to its corresponding Functional Specification (FS) and mapped to specific test cases in approved QMS Test Protocols (IQ/OQ). This structured traceability provides complete coverage, supports regulatory compliance, and delivers documented evidence that every GxP-critical function has been verified and validated according to its intended use.

  7. Summary Reporting: The Validation Summary Report (VSR) provides a comprehensive overview of how validation testing was executed and documents the results of all QMS validation activities. This report consolidates key elements such as executed IQ/OQ/PQ protocols, deviations and their resolutions, traceability to user requirements, and final compliance assessment. It serves as formal evidence that the system meets its intended use and regulatory requirements and includes documented approvals from Quality Assurance and system owners to confirm readiness for GxP production use.

    This report also covers the following:

    • Procedural Controls: SOPs/work instructions covering system administration, change management, incident management, data access, electronic records/signature controls, periodic review, and backup/restore testing.
    • Training and Qualification: Role-based training ensures users, administrators, and quality reviewers are qualified to use the system as validated.
    • Change and Release Management: Sustained compliance with the cloud-based QMS requires defined processes for vendor updates, patches, hotfixes, and configuration changes. Validation isn’t a one-time event; it’s lifecycle control.

Why This Matters for Regulatory Audits

Regulators require objective evidence that systems supporting GxP processes are properly validated and maintained in a controlled state throughout their lifecycle. During inspections, auditors frequently request documentation that demonstrates compliance and traceability, including:

  • Validation Plan and Summary Report
  • URFS, and Traceability Matrix
  • IQ/OQ/PQ protocols and executed results
  • SOPs and training records
  • Change control logs and release impact assessments

Having these artifacts readily available not only demonstrates compliance but also streamlines audits, reduces stress, and builds confidence with regulators. A proactive approach to documentation ensures transparency, supports continuous improvement, and reinforces your organization’s commitment to quality and data integrity. Arbour Group is your trusted partner for achieving validation readiness. Our proven validation methodology and deep GxP compliance expertise ensure your systems remain in a controlled state throughout the entire lifecycle. From strategic planning and execution to comprehensive documentation and audit support, we deliver the structure, rigor, and assurance needed to meet regulatory expectations with confidence.

Partner with Arbour Group for Confident, Compliant Cloud QMS Validation

As life sciences organizations continue to modernize quality operations, the ability to validate and sustain cloud-based QMS platforms has become essential to regulatory success and operational resilience. Arbour Group brings deep domain expertise, proven methodologies, and a risk-based mindset to help organizations confidently navigate cloud QMS validation while maintaining continuous compliance. Whether you are implementing a new QMS, transitioning to the cloud, or strengthening lifecycle controls for an existing system, Arbour Group is ready to support your journey. Contact our experts to learn how we can help you accelerate compliance, reduce validation risk, and build a quality foundation that scales with your business.

Posted by: J Espeleta, CISA

WHAT OUR CLIENTS THINK